← Back to Discover
Decheng Capital LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $731,749,074
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- CG ONCOLOGY INC · COM · 156944100 · shares: $452,707,083
- Nuvation Bio Inc. · COM · 67080N101 · shares: $147,421,214
- AARDVARK THERAPEUTICS INC · COM · 002942100 · shares: $22,563,642
- Aclaris Therapeutics, Inc. · COM · 00461U105 · shares: $21,380,783
- Upstream Bio Inc. · COM · 91678A107 · shares: $18,856,087
- Arcus Biosciences, Inc · COM · 03969F109 · shares: $14,329,137
- Equillium Inc. · COM · 29446K106 · shares: $14,231,386
- REVOLUTION MEDICINES INC(NSM) · COM · 76155X100 · shares: $9,863,476
- Lyell Immunopharma, Inc. · COM · 55083R104 · shares: $9,723,303
- BeyondSpring Inc. · SHS · G10830100 · shares: $6,651,229
Reported holdings
14 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| CG ONCOLOGY INC | COM | 156944100 | — | 6,371,669 shares | $452,707,083 |
| Nuvation Bio Inc. | COM | 67080N101 | — | 25,954,439 shares | $147,421,214 |
| AARDVARK THERAPEUTICS INC | COM | 002942100 | — | 3,917,299 shares | $22,563,642 |
| Aclaris Therapeutics, Inc. | COM | 00461U105 | — | 4,041,736 shares | $21,380,783 |
| Upstream Bio Inc. | COM | 91678A107 | — | 2,724,868 shares | $18,856,087 |
| Arcus Biosciences, Inc | COM | 03969F109 | — | 464,779 shares | $14,329,137 |
| Equillium Inc. | COM | 29446K106 | — | 4,447,308 shares | $14,231,386 |
| REVOLUTION MEDICINES INC(NSM) | COM | 76155X100 | — | 52,667 shares | $9,863,476 |
| Lyell Immunopharma, Inc. | COM | 55083R104 | — | 692,050 shares | $9,723,303 |
| BeyondSpring Inc. | SHS | G10830100 | — | 3,800,702 shares | $6,651,229 |
| Zentalis Pharmaceuticals Inc. | COM | 98943L107 | — | 1,323,327 shares | $6,418,136 |
| NEWAMSTERDAM PHARMA CO NV | COM | N62509109 | — | 176,887 shares | $5,994,700 |
| Pyxis Oncology, Inc (formerly Apexigen) | COM | 747324101 | — | 326,810 shares | $983,698 |
| TANGO THERAPEUTICS INC | COM | 87583X109 | — | 20,000 shares | $625,200 |